Inozyme Pharma CEO Axel Bolte's 2020 pay jumps 452% to $5.4M
Inozyme Pharma reports 2020 executive compensation
By ExecPay News
Published: April 27, 2021
Inozyme Pharma reported fiscal year 2020 executive compensation information on April 27, 2021.
In 2020, three executives at Inozyme Pharma received on average a compensation package of $2.5M, a 225% increase compared to previous year.
Average pay of disclosed executives at Inozyme Pharma
Axel Bolte, Chief Executive Officer, received $5.4M in total, which increased by 452% compared to 2019. 86% of Bolte's compensation, or $4.6M, was in option awards. Bolte also received $290K in non-equity incentive plan, $440K in salary, as well as $41K in other compensation.
Pedro Huertas, Chief Medical Officer, received a compensation package of $1.2M. 52% of the compensation package, or $605K, was in option awards.
Henric Bjarke, Chief Operating Officer, earned $1.1M in 2020, a 83% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2021.